This is a limited company view. Sign up for a Free Trial to see everything.

Neurotracks is a company that develops tools that enable physicians to predict Alzheimers disease before the symptoms appear.

B2B
Biotechnology
Fitness and Wellness
Healthcare
Medical Diagnostics
Pharmaceuticals

Overview

Location

Richmond

Founded

Employees

23

Stage

Series B

Total funding

$10M

Last funding

2 years ago

Acquisitions

0

Growth score

-200

Mindshare score

-227

Scoring

Deals

$1.0M Debt

Dec 29, 2014

$2.0M Series A

Founders Fund, Social Capital, Rock Health

Sep 26, 2013

$90.0K Seed

May 22, 2013

Undisclosed Amount Seed

Rock Health

Aug 1, 2012

Employee Growth

Use Neurotrack's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Neurotrack's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Associate Professor of Neurology, Keck School of Medicine of University of Southern California
Principal Consultant, Metis Cognition Ltd., Kilmington Common; Honorary Senior Lecturer, Dept. of Medicine, Imperial College, London
Senior Vice President
Director
Associate Professor of Neurology
SVP & Chief Research Officer, Lifespan Hospital System; Professor, Department of Neurology, Brown University
Group Director CV

Similar Companies

Patient-Centered Outcomes Research Institute

The Patient-Centered Outcomes Research Institute helps patients and their health care providers make more informed decisions.
Exited|325 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes